{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:14:55Z","timestamp":1768439695521,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","so-online.net","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.suronc.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T19:01:14Z","timestamp":1484766074000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Strategies to improve local control of resected pancreas adenocarcinoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Paul H.","family":"Sugarbaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2017.01.002_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.gassur.2006.08.018","article-title":"1423 pancreaticoduodenectomies for pancreatic cancer: a single institution experience","volume":"10","author":"Winter","year":"2006","journal-title":"J.\u00a0Gastrointest. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdq613","article-title":"Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4)","volume":"22","author":"Bertuccio","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.suronc.2017.01.002_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2017.01.002_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/bjs.5489","article-title":"Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer","volume":"94","author":"Holm","year":"2007","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","article-title":"Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial","volume":"11","author":"Songun","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2017.01.002_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"MacDonald","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.suronc.2017.01.002_bib7","first-page":"79","article-title":"New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperative intraperitoneal chemotherapy","volume":"2","author":"Sethna","year":"2004","journal-title":"Cancer Ther."},{"key":"10.1016\/j.suronc.2017.01.002_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0147-0272(86)80009-5","article-title":"Peritoneal carcinomatosis anatomy, physiology, diagnosis, management","volume":"10","author":"Spratt","year":"1968","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.suronc.2017.01.002_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000658-198904000-00003","article-title":"Total pancreatectomy for ductal cell carcinoma of the pancreas. An update","volume":"209","author":"Brooks","year":"1989","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ans.12640","article-title":"Total pancreatectomy for the treatment of pancreatic neoplasms","volume":"84","author":"Nikfarjam","year":"2014","journal-title":"ANZ J. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2017.01.002_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/SLA.0000000000000791","article-title":"Total pancreatectomy for primary pancreatic neoplasms. Renaissance of an unpopular operation","volume":"261","author":"Hartwig","year":"2015","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010244.pub2","article-title":"Resection versus other treatments for locally advanced pancreatic cancer (Review)","author":"Gurusamy","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.suronc.2017.01.002_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.sla.0000259391.84304.2b","article-title":"Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma","volume":"246","author":"Raut","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.surg.2005.06.044","article-title":"A\u00a0prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma","volume":"138","author":"Farnell","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2017.01.002_bib15","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00268-013-2064-z","article-title":"Extended lymphadenectomy in patients with pancreatic cancer is debatable","volume":"37","author":"Sergeant","year":"2013","journal-title":"World J. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1499-3872(11)60002-7","article-title":"Current opinion on lymphadenectomy in pancreatic cancer surgery","volume":"10","author":"Pavlidis","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.suronc.2017.01.002_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1477-7819-11-311","article-title":"Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer","volume":"11","author":"Xu","year":"2013","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2017.01.002_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1245\/s10434-007-9587-1","article-title":"Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis","volume":"15","author":"Slidell","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.suronc.2017.01.002_bib19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.surg.2006.12.013","article-title":"Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer","volume":"141","author":"Pawlik","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2017.01.002_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","article-title":"Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection","volume":"120","author":"Kalser","year":"1985","journal-title":"Arch. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/SLA.0b013e318156eef3","article-title":"Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891","volume":"246","author":"Smeenk","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2017.01.002_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cncr.28530","article-title":"Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base","volume":"120","author":"Colbert","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2017.01.002_bib23","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1200\/JCO.2016.67.5553","article-title":"Potentially curative pancreatic cancer: american Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Khorana","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"Suppl 4","key":"10.1016\/j.suronc.2017.01.002_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/annonc\/10.suppl_4.S226","article-title":"Studies of intraoperative radiotherapy in carcinoma of the pancreas","volume":"10","author":"Sindelar","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.suronc.2017.01.002_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semradonc.2013.11.004","article-title":"The role of intraoperative radiation therapy in patients with pancreatic cancer","volume":"24","author":"Palma","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.suronc.2017.01.002_bib26","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/j.ijrobp.2012.01.024","article-title":"Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan","volume":"83","author":"Jingu","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.suronc.2017.01.002_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.10000","article-title":"Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurrence of peritoneal carcinomatosis","volume":"79","author":"Ridwelski","year":"2002","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2017.01.002_bib28","first-page":"161","article-title":"Intraperitoneal gemcitabine chemotherapy as an adjuvant treatment for patients with resected pancreas cancer: phase II and pharmacologic studies","volume":"1","author":"Sugarbaker","year":"2012","journal-title":"Transl. Gastrointest. Cancer"},{"key":"10.1016\/j.suronc.2017.01.002_bib29","first-page":"171","article-title":"Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer","volume":"1","author":"Sugarbaker","year":"2012","journal-title":"Top. Anti-Cancer Res."},{"issue":"8","key":"10.1016\/j.suronc.2017.01.002_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/02656736.2016.1227094","article-title":"The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer","volume":"32","author":"Tentes","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.suronc.2017.01.002_bib31","first-page":"7 pages","article-title":"Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data","author":"Sugarbaker","year":"2011","journal-title":"Int. J. Surg. Oncol. Vol."},{"key":"10.1016\/j.suronc.2017.01.002_bib32","first-page":"1916","article-title":"Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans","volume":"41","author":"Speyer","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.suronc.2017.01.002_bib33","series-title":"Peritoneal Carcinomatosis: Principles of Management","first-page":"415","article-title":"A\u00a0simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor","author":"Sugarbaker","year":"1996"},{"key":"10.1016\/j.suronc.2017.01.002_bib34","first-page":"5 pages","article-title":"Adjuvant bidirectional chemotherapy using an intraperitoneal port","author":"Sugarbaker","year":"2012","journal-title":"Gastroenterol. Res. Pract. Vol."},{"issue":"10","key":"10.1016\/j.suronc.2017.01.002_bib35","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1245\/s10434-007-9487-4","article-title":"A\u00a0systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer","volume":"14","author":"Yan","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2017.01.002_bib36","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2014.55.9898","article-title":"Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study","volume":"33","author":"Tewari","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"3 Suppl 1","key":"10.1016\/j.suronc.2017.01.002_bib37","first-page":"S10","article-title":"S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis","volume":"5","author":"Kitayama","year":"2012","journal-title":"Gastrointest. Cancer Res."},{"issue":"8","key":"10.1016\/j.suronc.2017.01.002_bib38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","article-title":"A\u00a0comprehensive treatment for peritoneal metastases from gastric cancer with curative intent","volume":"42","author":"Yonemura","year":"2016","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416301220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416301220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T18:28:24Z","timestamp":1568744904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740416301220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0960740416301220"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2017.01.002","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to improve local control of resected pancreas adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}